Drug sales forecasting in the pharmaceutical market using deep neural network algorithms
DOI:
https://doi.org/10.6977/IJoSI.202409_8(3).0006Keywords:
drug sales forcasting, multilayer perception, Convolutional Neural Network, Long Short-Term MemoryAbstract
Drug sales and price forecasting have become an attractive investigation topic due to their important role in the pharmaceutical industry, A sales forecast helps every business to make better business decisions in overall business planning, budgeting, marketing, and risk management. The traditional forecasting method focuses on a conventional statistical model, which highly depends on the availability of historical sales data. However, for new drug entities, where not enough historical data is available, new methods of Machine Learning are applied. The aim of this paper is to identify an efficient Deep Neural Network algorithm suitable to forecast drug sales and pricing by applying Deep Neural Network Algorithms such as Multilayer Perceptron, Convolutional Neural Network, and Long Short-Term Memory, which are expected to perform well on this issue. The results are carried out to determine the efficiency of these algorithms by evaluating the performances of the models using MAE and RMSE performance metrics to identify the best algorithm for Drug Sales and Price Forecasting. The accepted accuracy should be more than 80\% of the actual value for quantity which is less than three thousand by unit and less than two dollars (USD) for price, Based on the results of the experiments Long Short Term Memory performed better than MLP and CNN for generating predictions with average Root Mean Square Error of for sales is 1.28(k) and Mean Absolute Error of about 0.85(k), and with average Root Mean Square Error for USD Prices is about 0.75, and Mean Absolute Error is about 0.44. The forecasts are then used to adjust stock levels according to the predictions.
Downloads
Published
Issue
Section
License
Copyright in a work is a bundle of rights. IJoSI's, copyright covers what may be done with the work in terms of making copies, making derivative works, abstracting parts of it for citation or quotation elsewhere and so on. IJoSI requires authors to sign over rights when their article is ready for publication so that the publisher from then on owns the work. Until that point, all rights belong to the creator(s) of the work. The format of IJoSI copy right form can be found at the IJoSI web site.The issues of International Journal of Systematic Innovation (IJoSI) are published in electronic format and in print. Our website, journal papers, and manuscripts etc. are stored on one server. Readers can have free online access to our journal papers. Authors transfer copyright to the publisher as part of a journal publishing agreement, but have the right to:
1. Share their article for personal use, internal institutional use and scholarly sharing purposes, with a DOI link to the version of record on our server.
2. Retain patent, trademark and other intellectual property rights (including research data).
3. Proper attribution and credit for the published work.